UManitoba strikes international partnership to understand mpox


The University of Manitoba and the National Biomedical Research Institute in the Democratic Republic of the Congo (DRC) have partnered to investigate the global spread of mpox and the virus behind the illness. “Unfortunately, we saw a global outbreak of mpox in 2022,” said project co-lead and UManitoba Assistant Professor Dr Jason Kindrachuk. “That has increased the spotlight on the virus, which is helpful for us to combat it, but we can’t let scientific interest fade now that cases are decreasing across most of the globe.” The researchers will study the movement of the virus, how it has changed, whether undetected transmission occurred, and how effective the Imvamune mpox vaccine is. The study has received $2.8M from the federal government.